Polar Capital’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Polar Capital’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-300,000	Closed	-$3.24M	–	285
2016 Q2	$3.24M	Buy	300,000 +190,000	+173%	+$1.62M	0.06%	202
2016 Q1	$729K	Buy	110,000 +87,392	+387%	+$795K	0.01%	245
2015 Q4	$409K	Buy	22,608 +3,597	+19%	+$49.5K	0.01%	254
2015 Q3	$209K	Sell	19,011 -3,227	-15%	-$34.3K	﹤0.01%	269
2015 Q2	$320K	Hold	22,238	–	–	0.01%	279
2015 Q1	$260K	Buy	+22,238	New	+$300K	﹤0.01%	279

Other funds holding VTAE

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Polar Capital's VTAE Position: Q3 2016 in Review

Polar Capital sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q3 2016, closing a stake of 300,000 shares — an estimated $3.24M sold.

Polar Capital first reported a position in VTAE in Q1 2015 and held it in 6 quarters. The position peaked at $3.24M in Q2 2016. 98 funds tracked by Wall St. Rank hold VTAE as of Q3 2016.

Polar Capital reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q3 2016 after selling out during the quarter.
Polar Capital sold 300,000 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q3 2016, an estimated $3.24M.
Polar Capital first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q1 2015 and held it in 6 quarters.
Polar Capital's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $3.24M in Q2 2016.
98 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q3 2016.

Based on Polar Capital's 13F filing for Q3 2016, filed 14 Nov 2016.